stella
beta
Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPC — Stella
Recruiting
Back to Recurrent Nasopharyngeal Carcinoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(8 sites)
China
The First Affiliated Hospital of USTC(University of Science and Technology of China), Hefei, Anhui
Fujian Medical University Union Hospital, Fuzhou, Fujian
Fujian Provincial Hospital, Fuzhou, Fujian
Shenzhen Second People's Hospital, Shenzhen, Guangdong
The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi
Show all 8 locations
View full record on ClinicalTrials.gov